Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Rheumatol. 2018 Jun 15;45(8):1145–1152. doi: 10.3899/jrheum.170868

Table 2.

COMPASS-31 scores and subdomain scores in scleroderma compared to previously published healthy controls (n=30) (20) and patients with other diseases that present with autonomic symptoms, including fibromyalgia (n=30) (20), diabetic polyneuropathy (n=29) (19), and small-fiber polyneuropathy (n=66) (17). Data are presented as mean (standard deviation).

Subdomain Scleroderma Healthy Controls Fibromyalgia Diabetic polyneuropathy Small-fiber polyneuropathy
Orthostatic 8.2 (9.3) 2.9 (6.4) 9.2 (8.5) 11.2 (12.4) 14.0 (12.4)
Vasomotor 2.6 (1.4) 0.1 (0.3) 0.8 (1.3) 1.0 (1.4) 1.6 (2.1)
Secretomotor 4.8 (3.3) 1.1 (2.4) 4.9 (3.2) 5.5 (3.6) 5.4 (6.9)
Gastrointestinal 7.7 (4.9) 3.1 (2.7) 8.4 (4.4) 8.1 (4.8) 6.6 (5.4)
Urinary 0.9 (1.3) 0.5 (0.9) 1.8 (1.6) 1.6 (2.0) 1.0 (1.6)
Pupillomotor 1.6 (1.1) 1.2 (0.8) 2.4 (1.1) 2.2 (1.3) 1.7 (1.4)
Total COMPASS-31 24.9 (15.5) 8.9 (8.7) 27.5 (14.2) 28.9 (19.1) 30.2 (23.2)